ED
DOG

Exane Derivatives’s ProShares Short Dow30 DOG Stock Holding History

Exane Derivatives’s Portfolio DOG Stock Details DOG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,500
Closed -$395K – 904
2021
Q3 		$395K Buy
+11,500
New +$385K 0.09% 232

Other funds holding DOG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ICG
InterOcean Capital Group Nashville, Tennessee $4.19B AUM 26.29% 1-Year Est. Return
TC
Telemus Capital Southfield, Michigan $1.21B AUM 23.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
DAS
Dynamic Advisor Solutions Phoenix, Arizona $3.53B AUM 22.61% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
LG
Leuthold Group Minneapolis, Minnesota $939M AUM 37.7% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Exane Derivatives's DOG Position: Q4 2021 in Review

Exane Derivatives sold out of ProShares Short Dow30 (DOG) in Q4 2021, closing a stake of 11,500 shares — an estimated $395K sold.

Exane Derivatives first reported a position in DOG in Q3 2021 and held it in 1 quarter. The position peaked at $395K in Q3 2021. 37 funds tracked by Wall St. Rank hold DOG as of Q4 2021.

  • Exane Derivatives reported no remaining ProShares Short Dow30 position as of Q4 2021 after selling out during the quarter.
  • Exane Derivatives sold 11,500 ProShares Short Dow30 shares in Q4 2021, an estimated $395K.
  • Exane Derivatives first reported a position in ProShares Short Dow30 in Q3 2021 and held it in 1 quarter.
  • Exane Derivatives's ProShares Short Dow30 position peaked at $395K in Q3 2021.
  • 37 funds tracked by Wall St. Rank held ProShares Short Dow30 as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.